English
简体中文
Total: £ 56.28
Published Date: 2025-09-18 | Pages: 81 | Tables: 82 | Medical Care
The global market for Septicemia Diagnostic Testing was valued at US$ 1024 million in the year 2024 and is projected to reach a revised size of US$ 1709 million by 2031, growing at a CAGR of 7.6% during the forecast period.
Septicemia diagnostic testing comprises the portfolio of in vitro diagnostics used for early detection, pathogen identification, host-response/biomarker assessment (e.g., PCT, CRP, gene-expression signatures), and point-of-care triage. It spans conventional blood culture and organism identification, rapid molecular pathogen assays, multiplex panels, and host-response tests that support risk stratification and therapeutic decisions. These diagnostics are central to emergency and ICU workflows, antimicrobial stewardship, and inpatient care pathways—shortening time-to-diagnosis, guiding targeted therapy, and improving outcomes.
The septicemia diagnostic testing market presents durable, structural growth opportunities driven by policy emphasis on early recognition and standardized sepsis management, hospital investments to upgrade point-of-care and microbiology capabilities, and rapid diagnostic innovation (e.g., direct-from-blood molecular assays, multiplex pathogen panels, and host-response biomarkers). Company annual reports and investor presentations emphasize that integrated portfolios—spanning rapid screening, pathogen confirmation and therapy monitoring—can materially improve hospital workflow efficiency and support antimicrobial stewardship, making such offerings procurement priorities for large health systems. Governmental and international health guidance for early diagnostics further create a policy-driven demand window.
Key challenges persist: clinical pathways vary across institutions, so adoption of novel diagnostics requires robust clinical evidence and implementation guidance; regulatory and reimbursement regimes differ by market, complicating cross-border commercialization and pricing; and the diagnostic value chain depends on high-quality reagents, automated platforms, and interoperable IT/AI—any supply-chain or integration shortfall can hinder adoption. Corporate annual reports repeatedly note that sustained clinical validation, hospital-implementation capabilities, and regulatory strategy are essential to mitigate these risks.Hospitals and clinical customers show two concurrent trends: a firm demand for faster and earlier diagnostics that places POC and rapid molecular tests high on ED and ICU procurement lists, and an expectation that results be actionable—tests must not only be fast and accurate but directly inform antimicrobial start/stop and stratified care. Public health initiatives encourage establishment of hospital sepsis programs and quality metrics, promoting deeper integration of diagnostics into clinical pathways; clinical buyers increasingly prefer bundled solutions that combine reagents, instruments and software/services—an evolution reflected in corporate annual reports and governmental hospital program guidance. The upstream supply base for sepsis diagnostics comprises high-grade reagents, enzymes and nucleic-acid extraction kits, disposable cartridges/chips, microfluidic and fluidics components, and the electronic and software modules that power platforms. Annual reports and sell-side research highlight that reagents and single-use consumables are both margin drivers and entry barriers; the stability and quality consistency of these supplies, along with local manufacturing capability, directly affect a vendor’s competitiveness in hospital tenders. Platform vendors emphasize upstream investments into hardware–software integration (including data analytics and AI), indicating future competition will focus on integrated “reagents + instruments + digital services” capabilities. Firms that invest in R&D and supply-chain resilience to secure high-quality upstream inputs at scale will build durable competitive moats.
This report aims to provide a comprehensive presentation of the global market for Septicemia Diagnostic Testing, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Septicemia Diagnostic Testing.
The Septicemia Diagnostic Testing market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Septicemia Diagnostic Testing market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Septicemia Diagnostic Testing companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation
By Company
BD
Thermo Fisher Scientific
bioMérieux
Danaher
Roche
Luminex
Philips
Bruker
Immunexpress
Abbott Laboratories
T2 Biosystems
Qiagen
Siemens Healthineers
Response Biomedical
Segment by Type
Blood Culture
Blood Test
Bacterial Examination
Imaging Test
Other
Segment by Application
Hospital
Third-party Laboratory
Other
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Chapter Outline
Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Septicemia Diagnostic Testing company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.
Research Methodology
The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:
★Stage 1 SECONDARY RESEARCH
The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.
★Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES
After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.
★Stage 3 ANALYSIS OF THE GATHERED DATA
The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.
★Stage 4 QUANTITATIVE DATA
The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.
★Stage 5 QUALITY CONTROL
Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Septicemia Diagnostic Testing Market Size Growth Rate by Type: 2020 VS 2024 VS 2031
1.2.2 Blood Culture
1.2.3 Blood Test
1.2.4 Bacterial Examination
1.2.5 Imaging Test
1.2.6 Other
1.3 Market by Application
1.3.1 Global Septicemia Diagnostic Testing Market Growth by Application: 2020 VS 2024 VS 2031
1.3.2 Hospital
1.3.3 Third-party Laboratory
1.3.4 Other
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Septicemia Diagnostic Testing Market Perspective (2020-2031)
2.2 Global Septicemia Diagnostic Testing Growth Trends by Region
2.2.1 Global Septicemia Diagnostic Testing Market Size by Region: 2020 VS 2024 VS 2031
2.2.2 Septicemia Diagnostic Testing Historic Market Size by Region (2020-2025)
2.2.3 Septicemia Diagnostic Testing Forecasted Market Size by Region (2026-2031)
2.3 Septicemia Diagnostic Testing Market Dynamics
2.3.1 Septicemia Diagnostic Testing Industry Trends
2.3.2 Septicemia Diagnostic Testing Market Drivers
2.3.3 Septicemia Diagnostic Testing Market Challenges
2.3.4 Septicemia Diagnostic Testing Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Septicemia Diagnostic Testing Players by Revenue
3.1.1 Global Top Septicemia Diagnostic Testing Players by Revenue (2020-2025)
3.1.2 Global Septicemia Diagnostic Testing Revenue Market Share by Players (2020-2025)
3.2 Global Top Septicemia Diagnostic Testing Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Global Key Players Ranking by Septicemia Diagnostic Testing Revenue
3.4 Global Septicemia Diagnostic Testing Market Concentration Ratio
3.4.1 Global Septicemia Diagnostic Testing Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Septicemia Diagnostic Testing Revenue in 2024
3.5 Global Key Players of Septicemia Diagnostic Testing Head office and Area Served
3.6 Global Key Players of Septicemia Diagnostic Testing, Product and Application
3.7 Global Key Players of Septicemia Diagnostic Testing, Date of Enter into This Industry
3.8 Mergers & Acquisitions, Expansion Plans
4 Septicemia Diagnostic Testing Breakdown Data by Type
4.1 Global Septicemia Diagnostic Testing Historic Market Size by Type (2020-2025)
4.2 Global Septicemia Diagnostic Testing Forecasted Market Size by Type (2026-2031)
5 Septicemia Diagnostic Testing Breakdown Data by Application
5.1 Global Septicemia Diagnostic Testing Historic Market Size by Application (2020-2025)
5.2 Global Septicemia Diagnostic Testing Forecasted Market Size by Application (2026-2031)
6 North America
6.1 North America Septicemia Diagnostic Testing Market Size (2020-2031)
6.2 North America Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
6.3 North America Septicemia Diagnostic Testing Market Size by Country (2020-2025)
6.4 North America Septicemia Diagnostic Testing Market Size by Country (2026-2031)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Septicemia Diagnostic Testing Market Size (2020-2031)
7.2 Europe Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
7.3 Europe Septicemia Diagnostic Testing Market Size by Country (2020-2025)
7.4 Europe Septicemia Diagnostic Testing Market Size by Country (2026-2031)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Septicemia Diagnostic Testing Market Size (2020-2031)
8.2 Asia-Pacific Septicemia Diagnostic Testing Market Growth Rate by Region: 2020 VS 2024 VS 2031
8.3 Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2020-2025)
8.4 Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2026-2031)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Septicemia Diagnostic Testing Market Size (2020-2031)
9.2 Latin America Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
9.3 Latin America Septicemia Diagnostic Testing Market Size by Country (2020-2025)
9.4 Latin America Septicemia Diagnostic Testing Market Size by Country (2026-2031)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Septicemia Diagnostic Testing Market Size (2020-2031)
10.2 Middle East & Africa Septicemia Diagnostic Testing Market Growth Rate by Country: 2020 VS 2024 VS 2031
10.3 Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2020-2025)
10.4 Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2026-2031)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 BD
11.1.1 BD Company Details
11.1.2 BD Business Overview
11.1.3 BD Septicemia Diagnostic Testing Introduction
11.1.4 BD Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.1.5 BD Recent Development
11.2 Thermo Fisher Scientific
11.2.1 Thermo Fisher Scientific Company Details
11.2.2 Thermo Fisher Scientific Business Overview
11.2.3 Thermo Fisher Scientific Septicemia Diagnostic Testing Introduction
11.2.4 Thermo Fisher Scientific Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.2.5 Thermo Fisher Scientific Recent Development
11.3 bioMérieux
11.3.1 bioMérieux Company Details
11.3.2 bioMérieux Business Overview
11.3.3 bioMérieux Septicemia Diagnostic Testing Introduction
11.3.4 bioMérieux Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.3.5 bioMérieux Recent Development
11.4 Danaher
11.4.1 Danaher Company Details
11.4.2 Danaher Business Overview
11.4.3 Danaher Septicemia Diagnostic Testing Introduction
11.4.4 Danaher Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.4.5 Danaher Recent Development
11.5 Roche
11.5.1 Roche Company Details
11.5.2 Roche Business Overview
11.5.3 Roche Septicemia Diagnostic Testing Introduction
11.5.4 Roche Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.5.5 Roche Recent Development
11.6 Luminex
11.6.1 Luminex Company Details
11.6.2 Luminex Business Overview
11.6.3 Luminex Septicemia Diagnostic Testing Introduction
11.6.4 Luminex Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.6.5 Luminex Recent Development
11.7 Philips
11.7.1 Philips Company Details
11.7.2 Philips Business Overview
11.7.3 Philips Septicemia Diagnostic Testing Introduction
11.7.4 Philips Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.7.5 Philips Recent Development
11.8 Bruker
11.8.1 Bruker Company Details
11.8.2 Bruker Business Overview
11.8.3 Bruker Septicemia Diagnostic Testing Introduction
11.8.4 Bruker Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.8.5 Bruker Recent Development
11.9 Immunexpress
11.9.1 Immunexpress Company Details
11.9.2 Immunexpress Business Overview
11.9.3 Immunexpress Septicemia Diagnostic Testing Introduction
11.9.4 Immunexpress Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.9.5 Immunexpress Recent Development
11.10 Abbott Laboratories
11.10.1 Abbott Laboratories Company Details
11.10.2 Abbott Laboratories Business Overview
11.10.3 Abbott Laboratories Septicemia Diagnostic Testing Introduction
11.10.4 Abbott Laboratories Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.10.5 Abbott Laboratories Recent Development
11.11 T2 Biosystems
11.11.1 T2 Biosystems Company Details
11.11.2 T2 Biosystems Business Overview
11.11.3 T2 Biosystems Septicemia Diagnostic Testing Introduction
11.11.4 T2 Biosystems Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.11.5 T2 Biosystems Recent Development
11.12 Qiagen
11.12.1 Qiagen Company Details
11.12.2 Qiagen Business Overview
11.12.3 Qiagen Septicemia Diagnostic Testing Introduction
11.12.4 Qiagen Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.12.5 Qiagen Recent Development
11.13 Siemens Healthineers
11.13.1 Siemens Healthineers Company Details
11.13.2 Siemens Healthineers Business Overview
11.13.3 Siemens Healthineers Septicemia Diagnostic Testing Introduction
11.13.4 Siemens Healthineers Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.13.5 Siemens Healthineers Recent Development
11.14 Response Biomedical
11.14.1 Response Biomedical Company Details
11.14.2 Response Biomedical Business Overview
11.14.3 Response Biomedical Septicemia Diagnostic Testing Introduction
11.14.4 Response Biomedical Revenue in Septicemia Diagnostic Testing Business (2020-2025)
11.14.5 Response Biomedical Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Septicemia Diagnostic Testing Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Blood Culture
Table 3. Key Players of Blood Test
Table 4. Key Players of Bacterial Examination
Table 5. Key Players of Imaging Test
Table 6. Key Players of Other
Table 7. Global Septicemia Diagnostic Testing Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 8. Global Septicemia Diagnostic Testing Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 9. Global Septicemia Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 10. Global Septicemia Diagnostic Testing Market Share by Region (2020-2025)
Table 11. Global Septicemia Diagnostic Testing Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 12. Global Septicemia Diagnostic Testing Market Share by Region (2026-2031)
Table 13. Septicemia Diagnostic Testing Market Trends
Table 14. Septicemia Diagnostic Testing Market Drivers
Table 15. Septicemia Diagnostic Testing Market Challenges
Table 16. Septicemia Diagnostic Testing Market Restraints
Table 17. Global Septicemia Diagnostic Testing Revenue by Players (2020-2025) & (US$ Million)
Table 18. Global Septicemia Diagnostic Testing Market Share by Players (2020-2025)
Table 19. Global Top Septicemia Diagnostic Testing Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Septicemia Diagnostic Testing as of 2024)
Table 20. Ranking of Global Top Septicemia Diagnostic Testing Companies by Revenue (US$ Million) in 2024
Table 21. Global 5 Largest Players Market Share by Septicemia Diagnostic Testing Revenue (CR5 and HHI) & (2020-2025)
Table 22. Global Key Players of Septicemia Diagnostic Testing, Headquarters and Area Served
Table 23. Global Key Players of Septicemia Diagnostic Testing, Product and Application
Table 24. Global Key Players of Septicemia Diagnostic Testing, Date of Enter into This Industry
Table 25. Mergers & Acquisitions, Expansion Plans
Table 26. Global Septicemia Diagnostic Testing Market Size by Type (2020-2025) & (US$ Million)
Table 27. Global Septicemia Diagnostic Testing Revenue Market Share by Type (2020-2025)
Table 28. Global Septicemia Diagnostic Testing Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 29. Global Septicemia Diagnostic Testing Revenue Market Share by Type (2026-2031)
Table 30. Global Septicemia Diagnostic Testing Market Size by Application (2020-2025) & (US$ Million)
Table 31. Global Septicemia Diagnostic Testing Revenue Market Share by Application (2020-2025)
Table 32. Global Septicemia Diagnostic Testing Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 33. Global Septicemia Diagnostic Testing Revenue Market Share by Application (2026-2031)
Table 34. North America Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 35. North America Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 36. North America Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 37. Europe Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 38. Europe Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 39. Europe Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 40. Asia-Pacific Septicemia Diagnostic Testing Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 41. Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2020-2025) & (US$ Million)
Table 42. Asia-Pacific Septicemia Diagnostic Testing Market Size by Region (2026-2031) & (US$ Million)
Table 43. Latin America Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 44. Latin America Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 45. Latin America Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 46. Middle East & Africa Septicemia Diagnostic Testing Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 47. Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2020-2025) & (US$ Million)
Table 48. Middle East & Africa Septicemia Diagnostic Testing Market Size by Country (2026-2031) & (US$ Million)
Table 49. BD Company Details
Table 50. BD Business Overview
Table 51. BD Septicemia Diagnostic Testing Product
Table 52. BD Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 53. BD Recent Development
Table 54. Thermo Fisher Scientific Company Details
Table 55. Thermo Fisher Scientific Business Overview
Table 56. Thermo Fisher Scientific Septicemia Diagnostic Testing Product
Table 57. Thermo Fisher Scientific Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 58. Thermo Fisher Scientific Recent Development
Table 59. bioMérieux Company Details
Table 60. bioMérieux Business Overview
Table 61. bioMérieux Septicemia Diagnostic Testing Product
Table 62. bioMérieux Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 63. bioMérieux Recent Development
Table 64. Danaher Company Details
Table 65. Danaher Business Overview
Table 66. Danaher Septicemia Diagnostic Testing Product
Table 67. Danaher Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 68. Danaher Recent Development
Table 69. Roche Company Details
Table 70. Roche Business Overview
Table 71. Roche Septicemia Diagnostic Testing Product
Table 72. Roche Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 73. Roche Recent Development
Table 74. Luminex Company Details
Table 75. Luminex Business Overview
Table 76. Luminex Septicemia Diagnostic Testing Product
Table 77. Luminex Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 78. Luminex Recent Development
Table 79. Philips Company Details
Table 80. Philips Business Overview
Table 81. Philips Septicemia Diagnostic Testing Product
Table 82. Philips Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 83. Philips Recent Development
Table 84. Bruker Company Details
Table 85. Bruker Business Overview
Table 86. Bruker Septicemia Diagnostic Testing Product
Table 87. Bruker Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 88. Bruker Recent Development
Table 89. Immunexpress Company Details
Table 90. Immunexpress Business Overview
Table 91. Immunexpress Septicemia Diagnostic Testing Product
Table 92. Immunexpress Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 93. Immunexpress Recent Development
Table 94. Abbott Laboratories Company Details
Table 95. Abbott Laboratories Business Overview
Table 96. Abbott Laboratories Septicemia Diagnostic Testing Product
Table 97. Abbott Laboratories Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 98. Abbott Laboratories Recent Development
Table 99. T2 Biosystems Company Details
Table 100. T2 Biosystems Business Overview
Table 101. T2 Biosystems Septicemia Diagnostic Testing Product
Table 102. T2 Biosystems Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 103. T2 Biosystems Recent Development
Table 104. Qiagen Company Details
Table 105. Qiagen Business Overview
Table 106. Qiagen Septicemia Diagnostic Testing Product
Table 107. Qiagen Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 108. Qiagen Recent Development
Table 109. Siemens Healthineers Company Details
Table 110. Siemens Healthineers Business Overview
Table 111. Siemens Healthineers Septicemia Diagnostic Testing Product
Table 112. Siemens Healthineers Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 113. Siemens Healthineers Recent Development
Table 114. Response Biomedical Company Details
Table 115. Response Biomedical Business Overview
Table 116. Response Biomedical Septicemia Diagnostic Testing Product
Table 117. Response Biomedical Revenue in Septicemia Diagnostic Testing Business (2020-2025) & (US$ Million)
Table 118. Response Biomedical Recent Development
Table 119. Research Programs/Design for This Report
Table 120. Key Data Information from Secondary Sources
Table 121. Key Data Information from Primary Sources
Table 122. Authors List of This Report
List of Figures
Figure 1. Septicemia Diagnostic Testing Picture
Figure 2. Global Septicemia Diagnostic Testing Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Septicemia Diagnostic Testing Market Share by Type: 2024 VS 2031
Figure 4. Blood Culture Features
Figure 5. Blood Test Features
Figure 6. Bacterial Examination Features
Figure 7. Imaging Test Features
Figure 8. Other Features
Figure 9. Global Septicemia Diagnostic Testing Market Size by Application (2020-2031) & (US$ Million)
Figure 10. Global Septicemia Diagnostic Testing Market Share by Application: 2024 VS 2031
Figure 11. Hospital Case Studies
Figure 12. Third-party Laboratory Case Studies
Figure 13. Other Case Studies
Figure 14. Septicemia Diagnostic Testing Report Years Considered
Figure 15. Global Septicemia Diagnostic Testing Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 16. Global Septicemia Diagnostic Testing Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 17. Global Septicemia Diagnostic Testing Market Share by Region: 2024 VS 2031
Figure 18. Global Septicemia Diagnostic Testing Market Share by Players in 2024
Figure 19. Global Septicemia Diagnostic Testing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 20. The Top 10 and 5 Players Market Share by Septicemia Diagnostic Testing Revenue in 2024
Figure 21. North America Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. North America Septicemia Diagnostic Testing Market Share by Country (2020-2031)
Figure 23. United States Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Canada Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 25. Europe Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. Europe Septicemia Diagnostic Testing Market Share by Country (2020-2031)
Figure 27. Germany Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. France Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. U.K. Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Italy Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Russia Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Ireland Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 33. Asia-Pacific Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Asia-Pacific Septicemia Diagnostic Testing Market Share by Region (2020-2031)
Figure 35. China Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Japan Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. South Korea Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Southeast Asia Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. India Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Australia & New Zealand Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 41. Latin America Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Latin America Septicemia Diagnostic Testing Market Share by Country (2020-2031)
Figure 43. Mexico Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Brazil Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 45. Middle East & Africa Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Middle East & Africa Septicemia Diagnostic Testing Market Share by Country (2020-2031)
Figure 47. Israel Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Saudi Arabia Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 49. UAE Septicemia Diagnostic Testing Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 50. BD Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 51. Thermo Fisher Scientific Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 52. bioMérieux Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 53. Danaher Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 54. Roche Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 55. Luminex Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 56. Philips Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 57. Bruker Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 58. Immunexpress Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 59. Abbott Laboratories Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 60. T2 Biosystems Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 61. Qiagen Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 62. Siemens Healthineers Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 63. Response Biomedical Revenue Growth Rate in Septicemia Diagnostic Testing Business (2020-2025)
Figure 64. Bottom-up and Top-down Approaches for This Report
Figure 65. Data Triangulation
Figure 66. Key Executives Interviewed
